Eagle Claw Capital Managment, LLC Pfizer Inc Transaction History
Eagle Claw Capital Managment, LLC
- $598 Million
- Q4 2024
A detailed history of Eagle Claw Capital Managment, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 27,181 shares of PFE stock, worth $726,548. This represents 0.12% of its overall portfolio holdings.
Number of Shares
27,181
Previous 27,644
1.67%
Holding current value
$726,548
Previous $800,000
9.88%
% of portfolio
0.12%
Previous 0.14%
Shares
23 transactions
Others Institutions Holding PFE
# of Institutions
3,370Shares Held
3.69BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$13.9 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.3 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.76 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$4.16 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA140MShares$3.74 Billion0.7% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $150B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...